scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1041757245 |
P356 | DOI | 10.1007/S12094-012-0786-2 |
P698 | PubMed publication ID | 22374425 |
P2093 | author name string | Gang Li | |
Ruxiang Xu | |||
Jianping Deng | |||
Shiming He | |||
Hongliu Lu | |||
Jianfang Fu | |||
Yanyang Tu | |||
P2860 | cites work | EphB4 expression and biological significance in prostate cancer | Q24304334 |
Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma | Q24647476 | ||
Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma | Q28137761 | ||
Mechanisms and functions of Eph and ephrin signalling | Q28208291 | ||
The Eph family of receptors | Q28251298 | ||
Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma | Q31105340 | ||
The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis | Q33677805 | ||
Novel EphB4 monoclonal antibodies modulate angiogenesis and inhibit tumor growth | Q33745300 | ||
Recurrent high-grade glioma: a diagnostic and therapeutic challenge | Q33864058 | ||
Clinical development of experimental therapies for malignant glioma. | Q34782295 | ||
Receptor tyrosine kinase EphB4 is a survival factor in breast cancer | Q35221906 | ||
Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment | Q36962774 | ||
The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth | Q37334601 | ||
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth | Q37682093 | ||
EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2. | Q39636239 | ||
Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression | Q39861032 | ||
Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade | Q39883638 | ||
The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma | Q40046746 | ||
EphB4 provides survival advantage to squamous cell carcinoma of the head and neck | Q40292503 | ||
EphB4 controls blood vascular morphogenesis during postnatal angiogenesis | Q40327178 | ||
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. | Q40365399 | ||
EphB receptor activity suppresses colorectal cancer progression | Q40405920 | ||
Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application | Q40554993 | ||
EphrinB2 and EphB4 expression in pterygia: new insights and preliminary results | Q42454748 | ||
Tumor vessels are Eph-ing complicated | Q43563869 | ||
Expression of Ephb2 and Ephb4 in breast carcinoma | Q44804369 | ||
Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers | Q48030369 | ||
Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue. | Q51776814 | ||
Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers. | Q54571370 | ||
Patients' and staff's experiences of multidisciplinary follow-up for high-grade glioma after radical radiotherapy. | Q55463219 | ||
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies | Q69898972 | ||
World Health Organization classification of tumors | Q73931466 | ||
Ephrin-B2 induces migration of endothelial cells through the phosphatidylinositol-3 kinase pathway and promotes angiogenesis in adult vasculature | Q79074131 | ||
P433 | issue | 3 | |
P921 | main subject | glioblastoma | Q282142 |
P304 | page(s) | 214-220 | |
P577 | publication date | 2012-03-01 | |
P1433 | published in | Clinical and Translational Oncology | Q15754324 |
P1476 | title | Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients | |
P478 | volume | 14 |
Q89514362 | Angiocrine endothelium: from physiology to cancer |
Q53403455 | Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions. |
Q55286883 | Differential Expression Patterns of Eph Receptors and Ephrin Ligands in Human Cancers. |
Q27000196 | Eph receptors as therapeutic targets in glioblastoma |
Q47146373 | Eph-B4 regulates adaptive venous remodeling to improve arteriovenous fistula patency. |
Q38878649 | EphB1 Suppression in Acute Myelogenous Leukemia: Regulating the DNA Damage Control System |
Q41520269 | EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation |
Q55456644 | EphB4 mediates resistance to antiangiogenic therapy in experimental glioma. |
Q42529862 | EphrinB2 drives perivascular invasion and proliferation of glioblastoma stem-like cells |
Q37153834 | EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance |
Q27015780 | Ephs and Ephrins in malignant gliomas |
Q37557031 | Expression of Potential Regulatory Genes in Abdominal Adipose Tissue of Broiler Chickens during Early Development |
Q64986508 | High serum Ephrin-B2 levels predict poor prognosis for patients with gastric cancer. |
Q38765961 | KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors |
Q37312725 | Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival |
Q98771280 | PDCD10-Deficiency Promotes Malignant Behaviors and Tumor Growth via Triggering EphB4 Kinase Activity in Glioblastoma |
Q58117045 | Receptor-Targeted Glial Brain Tumor Therapies |
Q64097285 | The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models |
Q47108317 | The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide |
Q37723106 | The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer |
Search more.